JOSEPH J. MANNING - 08 Sep 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Joseph J. Manning by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
08 Sep 2022
Net transactions value
-$1,440,301
Form type
4
Filing time
09 Sep 2022, 17:27:12 UTC
Previous filing
26 Aug 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $1,021,555 +23,008 +43% $44.40 76,253 08 Sep 2022 Direct
transaction ABT Common shares without par value Sale $2,461,856 -23,008 -30% $107.00 53,245 08 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -23,008 -100% $0.000000* 0 08 Sep 2022 Common Shares 23,008 $44.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).